CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-09). The draft was written by AI, all 3 cited sources were opened and checked for existence, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 134 · Search date 2026-07-09 · Methodology v0.6

5-HTP,
does it really help with Mood, appetite, and sleep?

30-Second Summary
C
Evidence Grade C · 43 · Safety caution
For this ingredient, safety and interaction checks matter more than the efficacy claim.
What the
research shows
5-HTP has old small-study signals for depressive symptoms, appetite, and sleep, but modern large independent RCT evidence is lacking. The Cochrane review concluded that for depression there were only 2 high-quality studies with 64 participants, and appetite and weight studies were also small and old.
What the
ads claim
Advertising bundles 'happy hormone,' 'serotonin,' 'appetite suppression,' and 'deep sleep' into one message. However, depression, appetite, and sleep are different clinical endpoints, and their evidence levels also differ.
*

Useful facts when choosing a product

  • Supplement doses commonly use 50-200 mg per serving, but older studies sometimes used higher total amounts.
  • Caution is needed when combined with serotonergic drugs or herbs such as SSRIs, SNRIs, MAOIs, triptans, and St. John's wort.
  • Adverse effects such as nausea, diarrhea, drowsiness, and vivid dreams are reported.
  • The relationship with EMS includes contamination issues, but Cochrane also noted safety uncertainty.
Gap Measurement · Verdict 134 · C 43
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

The Shaw 2002 Cochrane review examined 5-HTP and tryptophan studies for depression and stated that only 2 RCTs, totaling 64 participants, were eligible for inclusion. Effect estimates looked better than placebo, but study quality was low and not conclusive. For appetite and weight, small RCTs by Cangiano 1992/1998 showed signals that 5-HTP reduced food intake and body weight, but samples were small, duration was short, and the studies are distant from modern obesity-treatment research standards. Sleep evidence centers on the mechanism as a melatonin precursor and some small or combination-product studies, so the evidence for 5-HTP alone is weak.

02

Why this is classified as C (43)

For depression and appetite, there are positive human signals, so this is not ? or D. However, the core evidence is old and small, and sleep-alone claims are weaker. Reflecting composite-claim separation and safety uncertainty, it is judged at the lower end of C, 43 points.

Counterpoint. Depression, insomnia, and appetite problems under drug treatment have a different risk-benefit context from general supplement use. This judgment is an evidence grade for general health-functional-food style claims.

Rejudgment record. Draft — Human signals exist, but quality is low, claims are composite, and safety requires caution.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Shaw KA et al. 2002Cochrane review64Independent reviewDepressive symptomsThere was a signal versus placebo, but the quality of evidence was not conclusive.Core
Cangiano C et al. 1992Randomized placebo-controlled trialUnknownFood intake and body weightReported a signal that 5-HTP reduced food intake and body weight.Supporting
Cangiano C et al. 1998Randomized placebo-controlled trial2UnknownCalorie intake and body weightReported a short-term signal for reduced food intake.Supporting
Turner EH et al. 2006Narrative reviewUnknownEvidence and safety for serotonin precursorsSummarized the pharmacology, limited clinical evidence, and interaction potential of 5-HTP.Supporting
§

Receipt — 3 References

Every cited source was opened and checked against the live page on 2026-07-09.

Shaw KA, Turner J, Del Mar C. Tryptophan and 5-Hydroxytryptophan for depression. Cochrane Database Syst Rev. 2002. DOI: 10.1002/14651858.CD003198.
checked
Cangiano C, et al. Eating behavior and adherence to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J Clin Nutr. 1992.
checked
Turner EH, Loftis JM, Blackwell AD. Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacol Ther. 2006;109:325-338.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-09 · Corrections: none

Cite this verdict

5-HTP x mood, appetite, and sleep Evidence Grade C card
[Chamgap] 5-HTP x mood, appetite, and sleep — Evidence Grade C·43. 3 cited sources checked. Source: https://health-receipt.pages.dev/en/verdicts/mood/5htp-mood-appetite-sleep/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.